| Application no. and date | 00925114.1 (espacenet) (Federated) (European Patent Register), 20000315 | | Patent/reg. no. and date | DK/EP 1162995, 20030604 | | Publication date | 20011219 | | Priority no. and date | DE 19911778, 19990317 | | EP pub. no. and date |
EP 1162995 20011219 | | Effective date | | | Applicant/owner | Solvay Pharmaceuticals GmbH, Hans-Böckler-Allee 20
30173 Hannover, DE | | Applicant ref. no. | P200201561 | | Inventor | SANDER, Suntje, Berta-von-Suttner-Platz 24
D-30173 Hannover, DE,
STEINBORN, Claus, Im Busche 2
D-30926 Seelze, DE,
RUDMANN, Martin, Reiherstieg 30
D-29339 Wathlingen, DE,
SCHWANITZ, Dieter, Breslauerstrasse 2
D-31036 Eime, DE,
HENNIGES, Friederike, Roonstrasse 18
D-38102 Braunschweig, DE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/46 (2006.01) , A61P 3/10 (2006.01) | | Title | Enzymer til behandling af diabetes mellitus type I | | Int. application no. | EP2000002261 | | Int. publication no. | WO2000054799 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
